Best Life Sciences Companies in Bristol, United Kingdom
The 31 best Life Sciences companies in Bristol, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Micrima.
Our analysis of 62 Life Sciences companies
$9.8b in tracked funding; 75% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2026.
Ranked: Best Life Sciences companies in Bristol
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Micrima Provider of non-invasive and a non-ionizing radio wave technology for detecting breast cancer. | $17M | 66 mo ago | Series A | 25 | 2005 | Roy Johnson Founder & Chairman | 52 patents Digital breast imaging and artifact-compensated medical imaging technologies | — |
| 2 | CytoSeek Developer of cell therapies for targeting solid tumours | $7M | 38 mo ago | Series A | 9 | 2017 | — | 7 patents Engineered globin‑based antitumor cells and dextran crosslinkers for targeted protein immunotherapy | — |
| 3 | Scarlet Therapeutics Developer of cell-based therapeutics to treat a wide range of diseases 14Talent top 28%Funding bottom 47%Global bottom 37%Market bottom 18% All 4 signals ▾Talenttop 28% Fundingbottom 47% Globalbottom 37% Marketbottom 18% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $7.1M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 14/100 | $7M | 6 mo ago | Series A | 3 | 2022 | Jan Frayne Co-Founder & CTO | — | — |
| 4 | Open Bionics Manufactures robotic prosthetic hand | $7M | 94 mo ago | Series A | 32 32 → 58 (+81%) | 2014 | Samantha Payne Co Founder and COO | 33 patents advanced 3D-printed bionic prosthetic hands with sensory feedback | — |
| 5 | Pertinax Pharma Deveeloper of antimicrobial technologies for various applications | $3M | 90 mo ago | Seed | 1 | 2015 | Michele Barbour Chief Executive Officer | — | — |
| 6 | Carbometrics Developer of glucose monitoring solution for diabetes | $3M | 30 mo ago | Seed | 13 | 2018 | Anthony Davis Co-Founder & Director | 3 patents Carbohydrate detection sensors for measuring saccharides in analytical devices | — |
| 7 | Fluoretiq Developer of a diagnostic platform for bacterial identification | $2M | 56 mo ago | Seed | 9 | 2017 | — | 4 patents Fluorescence-based biosensing probes for cellular material and bacterial detection | — |
| 8 | Argonaute RNA Provider of RNA-based therapeutics | $2M | 27 mo ago | Seed | 7 | 2015 | Anthony Parker CEO | 46 patents RNA interference therapeutics using double‑stranded RNA/DNA conjugates for gene silencing | — |
| 9 | Halo Therapeutics Developer of therapeutics for the treatment of Covid-19 | $2M | 41 mo ago | Seed | 1 | 2020 | Daniel Fitzgerald Co-Founder & CEO | — | — |
| 10 | EarSwitch Developer of a device to detect intentional movement of the eardrum | $2M | 32 mo ago | Seed | 1 | 2019 | Nick Gompertz Co-Founder & CEO | 55 patents Ear-based biometric capture, gesture detection, and ultrasound sensing for user interfaces | — |
| 11 | Ziylo Biosensor platform for carbohydrates | $944K | 128 mo ago | Acquired | 4 | 2014 | — | 10 patents Patents concentrated in health & consumer products | — |
| 12 | Ferryx Developer of probiotics for gastrointestinal inflammatory diseases | $827K | 39 mo ago | Seed | 4 | 2019 | Tristan Cogan Co-Founder | — | — |
| 13 | NuNano Provider of construction services for new builds, refurbishments, and facades | $515K | 115 mo ago | Seed | 11 11 → 12 (+9%) | 2011 | — | — | — |
| 14 | Azul Optics Device for assessing the eye health against damaging light | $362K | 91 mo ago | Seed | 4 | 2016 | — | 3 patents Ophthalmic vision testing devices and methods for visual acuity assessment | — |
| 15 | GenomeKey Developer of diagnostic solutions for infectious diseases by using DNA sequencing and machine learning | $259K | 27 mo ago | Seed | 10 | 2011 | Michael Roberts Co-Founder & CEO | — | — |
| 16 | Bioinduction Implanted neuromodulation devices for chronic pain management | $133K | 100 mo ago | Acquired | 10 | 2002 | — | 31 patents Implantable neuromodulation devices and methods for deep brain stimulation therapy. | — |
Top 12 Life Sciences companies in Bristol
#1
Series A · Bristol, England · founded 2022 · 3 employees$7.1Mraised▾
Developer of cell-based therapeutics to treat a wide range of diseases. The company is focused on developing a proprietary platform to generate novel red blood cell-based therapeutics to potentially treat a wide range of diseases including metabolic diseases, autoimmune diseases, infectious diseases and cancer.
- May 2026Series A$3.8M
- Nov 2024Seed$959.8K
- May 2023Seed—
- Aug 2022Seed$2.4M
#2
Series A · Bristol, England · founded 2017 · 9 employees$7.3Mraised▾
Developer of cell therapies for targeting solid tumors. The company is developing therapies for cancer, heart disease, osteoarthritis, and diabetic wound healing. They have developed artificial membrane-binding proteins that enable tissue-specific targeting and enhanced cell survivability.
- Sep 2023Series A$918.8K
- Mar 2021Series A$5M
- Nov 2019Grant (prize money)—
- May 2019Seed$1.4M
#3
Seed · Bristol, England · founded 2015 · 7 employees$2.3Mraised▾
Provider of RNA-based therapeutics. The technology harnesses a cell mechanism that inhibits the expression of a specific gene and thereby inhibits the production of a specific protein. They have developed a tool to stabilize siRNA for using it as a therapeutic.
- Jul 2024Seed$2.3M
#4
Series A · Bristol, England · founded 2005 · 25 employees$16.7Mraised▾
Provider of non-invasive and non-ionizing radio wave technology for detecting breast cancer. The company's MARIA system received European regulatory approval in 2015 and is currently deployed in clinical trials based at several breast cancer imaging centres throughout the UK.
- Apr 2021Series A$5.1M
- Mar 2018Series A$6.3M
- Aug 2016Series A—
- Apr 2016Series A$3.7M
#5
Seed · Bristol, England · founded 2018 · 13 employees$2.6Mraised▾
Developer of glucose monitoring solution for diabetes. The platform has developed the proprietary molecule biomimetic glucose binding molecule, It is the glucose-sensing molecule that can monitor the glucose level in diabetes patient.
- May 2024Seed$2.6M
#6
Seed · Bristol, England · founded 2019 · 1 employees$1.5Mraised▾
Developer of a device to detect intentional movement of the eardrum. EarSwitch is a smart device that uses in-ear biometric switches and sensor technology to detect intentional movement of the eardrum by one of the smallest muscles in the body that provides a completely unique communication option, especially for people with severe disabilities who are unable to communicate and control their environment.
- Feb 2024Seed$1.5M
- May 2023Grant (prize money)$1.2M
- Apr 2023Seed—
- Jul 2022Seed—
#7
Funding Raised · Bristol, England · founded 2021 · 4 employees$31.3Kraised▾
Manufacturer of carbon dots for the delivery of genetic material into plant cells. It offers sustainable agriculture solutions through its innovative agrochemical delivery methods, enabling safer and more powerful crop protection. The company utilizes carbon nanodots, derived from sugars and amino acids, to improve agricultural efficiency and reduce the use of toxic chemicals. By leveraging RNAi technology, it aims to drive a revolution in the agritech sector and address climate change challenges. Its groundbreaking technology has the potential to transform the agricultural industry.
- 2025Grant (prize money)$31.3K
#8
Seed · Bristol, England · founded 2020 · 1 employees$1.9Mraised▾
Developer of therapeutics for the treatment of Covid-19. The company has developed proprietary pan coronavirus antiviral treatments such as HLTX-1 and HLTX-2 inhaled sprays to inhibit pathogenic human coronaviruses. Also developed small molecules of HLTX-3 GPR40 agonists to treat acute infections.
- May 2023Seed$1.9M
#9
Series A · Bristol, England · founded 2014 · 32 employees$7Mraised▾
Open Bionics designed a low-cost robotic prosthetic hand using 3D printing. This robotic hand senses muscle contractions and expansions an understands the variations in muscle movements and performs the task much similar to a normal hand. This is light-weight and low-cost robotic hand got a crowdfunding of $67.5k through Indiegogo campaign. The company has won Inclusive Technology Prize, prosthetic innovation award by Limbless Association Prosthetic and Orthotics Awards, and was listed in the top 50 robotics company in international RBR50 list.
- Jan 2019Series A$6.4M
- Mar 2017Seed$579.3K
- Dec 2016Seed—
#10
Seed · Bristol, England · founded 2011 · 10 employees$259.3Kraised▾
Developer of diagnostic solutions for infectious diseases by using DNA sequencing and machine learning. The company has developed solutions that help to diagnoses bacterial presence, species, and antimicrobial resistance in humans. It uses artificial intelligence for the diagnosis of sepsis & other infectious diseases.
- Aug 2024Grant (prize money)$11.4M
- May 2022Grant (prize money)$1.2M
- May 2021Grant (prize money)—
- Jan 2021Seed$259.3K
#11
Seed · Bristol, England · founded 2019 · 4 employees$827.5Kraised▾
Developer of probiotics for gastrointestinal inflammatory diseases. It offers live biotherapeutic products for human and veterinary use with lead product FX856, a live bacterial product which can be used for the prevention or treatment of gastrointestinal inflammation in humans or animals.
- Jul 2023Seed$107K
- Sep 2022Seed$320.6K
- Apr 2022Seed$399.9K
#12
Seed · Bristol, England · founded 2017 · 9 employees$2.5Mraised▾
Developer of a diagnostic platform for bacterial identification. They have developed a technology that enables the identification of harmful bacteria. The technology is focused on glycan chemistry and quantum optics. The bacterias are identified by proprietary nano-material labels using an optical measurement system.
- Feb 2022Seed$1.5M
- Sep 2019Seed—
- May 2019Seed$973.9K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Bristol researches in biotechnology
- University of Bristol10
- Bristol-Myers Squibb3
- Bristol-Myers Squibb3
- At Bristol2
- Max Planck-Bristol Centre for Minimal Biology2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.